After the strong price increase that has been seen over the past few weeks, it appears opportune to anticipate a correction phase for shares in Klépierre, as the resistance around 34.9 EUR approaches. Investors should open a short trade and target the € 32.3.
The company has poor fundamentals for a short-term investment strategy.
The group's activity appears highly profitable thanks to its outperforming net margins.
Historically, the company has been releasing figures that are above expectations.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
This company will be of major interest to investors in search of a high dividend stock.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
The stock is close to a major daily resistance at EUR 34.9, which should be gotten rid of so as to gain new appreciation potential.
According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
One of the major weak points of the company is its financial situation.
The company's "enterprise value to sales" ratio is among the highest in the world.
Below the resistance at 35.27 EUR, the stock shows a negative configuration when looking looking at the weekly chart.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.